LEADER 01365nas  2200457-  450 
001 996412147503316
005 20230404213020.0
011   $a2692-3114
024 7 $a10.37349/etat
035   $a(DE-599)ZDB3049652-4
035   $a(OCoLC)1156240965
035   $a(CKB)4100000011870679
035   $a(CONSER)--2020201020
035   $a(EXLCZ)994100000011870679
100   $a20200601a20209999  o--            a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aExploration of targeted anti-tumor therapy
210  1$aElmhurst, New York :$cOpen Exploration,$d[2020]-
215   $a1 online resource
300   $aRefereed/Peer-reviewed
531 0 $aExplor. target. anti-tumor ther.
531 10$aExplor Target Antitumor Ther
606   $aTumors$xTreatment$vPeriodicals
606   $aTumors$xTreatment$2fast$3(OCoLC)fst01158791
606   $aNeoplasms$xtherapy
606   $aAntineoplastic Agents
608   $aPeriodicals.$2fast
608   $aPeriodical
615  0$aTumors$xTreatment
615  7$aTumors$xTreatment.
615 12$aNeoplasms$xtherapy
615 22$aAntineoplastic Agents
676   $a571.978
906   $aJOURNAL
912   $a996412147503316
996   $aExploration of targeted anti-tumor therapy$92579650
997   $aUNISA